Clonal analysis of bilateral mammary carcinomas by clinical evaluation and partial allelotyping

American Journal of Clinical Pathology

Volumn 120, Issue 2, 2003, Pages 168-174

  Tse, Gary M K ^a   Kung, Fred Y L ^a   Chan, Amy B W ^a   Law, Bonita K B ^a   Chang, Alexander R ^a   Lo, Kwok Wai ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Allelotyping; Bilateral; Breast; Carcinoma; Loss of heterozygosity

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER GRADING; CARCINOMA IN SITU; CHROMOSOME 11P; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 3P; CHROMOSOME MARKER; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DNA EXTRACTION; FEMALE; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PARTIAL ALLELOTYPING; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; BREAST TUMOR; CELL CLONE; CHEMISTRY; COMPARATIVE STUDY; GENETICS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIPLE CANCER; PATHOLOGY; POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SECOND CANCER;

BIOLOGICAL MARKER; DNA; MICROSATELLITE DNA;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CARCINOMA IN SITU; CLONE CELLS; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS;

EID: 85047687267     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/6YEPMCHACPG2BD15     Document Type: Article

References (22)

1. Abdalla I, Thisted RA, Heimann R. The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy. Cancer J. 2000;6:266-272.
2. Broet P, de la Rochefordiere A, Scholl SM, et al. Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol. 1995;13:1578-1583.
3. Heron DE, Komarnicky LT, Hyslop T, et al. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer. 2000;88:2739-2750.
4. Kelmendi de Ustarán J, Meiss RP. Primary synchronous bilateral breast cancer: epidemiological approach. Breast Cancer Res Treat. 1988;12:311-314.
5. Graham MD, Yelland A, Peacock J, et al. Bilateral carcinoma of the breast. Eur J Surg Oncol. 1993;19:259-264.
6. Bernstein JL, Thompson WD, Risch N, et al. The genetic epidemiology of second primary breast cancer. Am J Epidemiol. 1992;136:937-948.
7. Gollamudi SV, Gelman RS, Peiro G, et al. Breast-conserving therapy for stage I-II synchronous bilateral breast carcinoma. Cancer. 1997;79:1362-1369.
8. Sterns EE, Fletcher WA. Bilateral cancer of the breast: a review of clinical, histological, and immunohistologic characteristics. Surgery. 1991;110:617-622.
9. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer, I: the value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-410.
10. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. 2nd ed. New York, NY: Cold Spring Harbor Laboratory Press; 1989:9.16-9.20.
11. Lo KW, Teo PM, Hui AB, et al. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res. 2000;60:3348-3353.
12. Chaudary MA, Millis RR, Hoskins EO, et al. Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg. 1984;71:711-714.
13. Kume H, Oda H, Nakatsuru Y, et al. Genetic identification of bilateral primary or metastatic nonpapillary renal cell carcinoma. BJU Int. 2000;86:208-212.
14. Barsky SH, Grossman DA, Ho J, et al. The multifocality of bronchioloalveolar lung carcinoma: evidence and implications of a multiclonal origin. Mod Pathol. 1994;7:633-640.
15. Shimizu S, Yatabe Y, Koshikawa T, et al. High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis. Clin Cancer Res. 2000;6:3994-3999.
16. Hsu HC, Chiou TJ, Chen JY, et al. Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules. Hepatology. 1991;13:923-928.
17. Osborne RJ, Hamshere MG. A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer. Cancer Res. 2000;60:3706-3712.
18. Shen CY, Yu JC, Lo YL, et al. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. Cancer Res. 2000;60:3884-3892.
19. Janschek E, Kandioler-Eckersberger D, Ludwig C, et al. Contralateral breast cancer: molecular differentiation between metastasis and second primary cancer. Breast Cancer Res Treat. 2001;67:1-8.
20. Raabe NK, Sauer T, Erichsen A, et al. Breast cancer in the contralateral breast: incidence and histopathology after unilateral radical treatment of the first breast cancer. Oncol Rep. 1999;6:1001-1007.
21. Mose S, Adamietz IA, Thilmann C, et al. Bilateral breast carcinoma versus unilateral disease: review of 498 patients. Am J Clin Oncol. 1997;20:541-545.
22. Newman LA, Sahin AA, Cunningham JE, et al. A case-control study of unilateral and bilateral breast carcinoma patients. Cancer. 2001;91:1845-1853.